Medline ® Abstract for Reference 39
of 'Treatment of relapsed or refractory acute myeloid leukemia'
A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantation.
Murata M, Nishida T, Haneda M, Kanie T, Taji H, Iida H, Suzuki R, Hamaguchi M, Minami S, Kodera Y
Br J Haematol. 1999;105(3):799.
Twenty adult patients with high-risk leukaemia underwent allogeneic haemopoietic stem cell transplantation after melphalan, busulphan and total body irradiation followed by short-term methotrexate and low-dose cyclosporine or tacrolimus. Three patients developed veno-occlusive disease and no patient developed renal dysfunction. Seven patients experienced grade II-IV acute graft-versus-host disease (aGVHD) and five patients experienced grade III-IV. The 3-year probabilities of relapse and leukaemia-free survival were 22 +/- 11% (95% confidence interval) and 50 +/- 11%, respectively. These data suggest that this preconditioning regimen followed by a low-dose immunosuppressant provided a more anti-leukaemic effect without increased regimen-related toxicity and aGVHD.
Division of Haematology, Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.